You are here

P&T News

March 27

Devices may not power up, charge, or deliver shock therapy
Scientists find previously unknown genetic changes that predispose patients to glioma
New patent battle focuses on Sovaldi, which costs thousands of dollars for a course
Developers to file NDA in second half of 2017
Controversies are critiqued and data-derived recommendations are proposed

March 24

The human anti-PD-L1 antibody is the first therapy for this rare skin cancer
CTSA program paves way for nationwide single IRB model
MRIs more dependable than patient preference to determine best approach
John Hopkins experts call for early-detection strategies
Scientists working to develop the potential of nuclear receptors

March 23

Retrospective data must be confirmed in clinical trials
Health care job growth is down 23% compared with last year
Senators complain about drug makers’ abuses
Ocrevus and Dupixent set to make a splash

March 22

Two dozen Republicans oppose the plan
Former FDA heads say imported medications are too risky
Monoamine oxidase B inhibitor approved as add-on to levodopa
Treatment debuted at annual cost of $94,500

Pages